Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development

2021159 citationsJournal Articlegold Open Access

Authors

Abstract

ADAM9, EFNB2, MET, TMOD3, TPX2, and WNT7A are potent antigens for developing anti-PAAD mRNA vaccine, and patients with IS4 and IS5 tumors are suitable for vaccination.

Topics & Keywords

Pancreatic and Hepatic Oncology Research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Molecular Cancer

Volume 20, Issue 1, pp. 44-44

DOI: 10.1186/s12943-021-01310-0

Field-Weighted Citation Impact: 14.57